Immucell Corp
- Last sale
- Nov 6, 2026 · -0.80%
- Market cap
- $89.64M
- 9.09M shares
- Filings
- 799
Q3 2026+4.3% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+1.3% FY25 yoy
- $89.64M
- 47.7×
- 2.7×
- 2.7×
- 6.03%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $27,644,174 | reported | |
| FY 2024 | 2024-12-31 | $26,493,169 | reported | |
| FY 2023 | 2023-12-31 | $17,471,669 | reported | |
| FY 2022 | 2022-12-31 | $18,567,962 | reported | |
| FY 2021 | 2021-12-31 | $19,242,969 | reported | |
| FY 2020 | 2020-12-31 | $15,342,204 | reported | |
| FY 2019 | 2019-12-31 | $13,722,872 | reported | |
| FY 2018 | 2018-12-31 | $10,986,297 | reported | |
| FY 2017 | 2017-12-31 | $10,431,091 | reported | |
| FY 2016 | 2016-12-31 | $9,543,961 | reported | |
| FY 2015 | 2015-12-31 | $10,228,689 | reported | |
| FY 2014 | 2014-12-31 | $7,596,874 | reported |
Segments
LineFY2025ShareChange
Corporate Segment, Scours$27.45M99%+4.3%
Corporate Segment, Mastitis$196.39K0.7%+9.8%
Mastitis———
Other———
Scours———
Total$27.64M
In vitro & in vivo diagnostic substances
Immucell Corp is the 8th largest of the 20 covered companies the SEC files under this code, by revenue. SIC 2835
CompanyRevenueGrowthNet marginMarket cap
NTLAIntellia Therapeutics, Inc.$67.7M16.9%609.9%$1.5BTKNOAlpha Teknova, Inc.$40.5M7.4%42.6%$521.8M
ICCCImmucell Corp (this company)$27.6M4.3%3.8%$89.6M
AWHLAspira Women's Health Inc.$9.2M0.4%138.7%$16.3MNNNNAnbio Biotechnology$8.6M5.6%74.1%$554.7MBMRABiomerica Inc$4.5M16.2%84.8%$5.9MIMDXInsight Molecular Diagnostics Inc.$4.1M115.6%1,238.5%$75.3MVNRXVolitionrx Ltd$1.7M40.0%1,352.2%$6.7MCLDXCelldex Therapeutics, Inc.$1.5M78.0%16,748.0%$2.2BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Immucell Corp · CIK 811641 · Engraved from SEC EDGAR